Home » Market News » DirectorsTalk Highlights » Toni Braxton Opens Up About Living with Lupus
Immupharma Plc

Toni Braxton Opens Up About Living with Lupus

When autoimmune disease strikes, entire families are affected. Toni Braxton, 52, was diagnosed with lupus in 2008. At the time, she had to conjure up a way to carefully explain to her young children why she’d been in and out of the hospital for months.

“I remember having to tell my kids that I have lupus. It was difficult,” Braxton tells Prevention.com. The “Long As I Live” singer said her sons Diezel and Denim didn’t understand why their mom’s own immune system was attacking her perfectly healthy cells to make her sick. “I remember that feeling. He cried and said, ‘mommy’s ok,'” Braxton recalls her son saying.

Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.